Clinical Trial Update: Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating inhaled interferon gamma-1b for cystic fibrosis has completed, sponsored by InterMune.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: InterMune | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED